CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

A Debate on the Metabolic Syndrome: Evolving Challenges and Controversies CME/CE
Robert D. Toto, MD; James R. Sowers, MD; Kenneth A. Jamerson, MD
Disclosures

Release Date: September 28, 2005; Valid for credit through August 31, 2007

Credits Available
Physicians - up to 2.0 AMA PRA Category 1 continuing physician education credits ;
Nurses - up to 2.4 ANCC continuing nurse education contact hours

This CME/CE activity is based on transcripts and slides of presentations as delivered by the faculty at the "A Debate on the Metabolic Syndrome: Evolving Challenges and Controversies" symposium held at the National Kidney Foundation's Clinical Meetings on May 6, 2005.

Contents of This CME/CE Activity
This activity is offered in two formats. Please choose one of the versions:

    Flash Version
    (A multimedia presentation with synchronized audio and slides.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript:

  1. Who Are the Metabolic Syndrome Patients and Why Do They Have Increased Cardiorenal Risk?
    by James R. Sowers, MD
    Metabolic Syndrome: Some Demographics
    Causes of the Epidemic
    Diabetes/Metabolic Syndrome and Cardiovascular Disease
    Metabolic Syndrome and Impaired Endothelium-Dependent Vasodilation
    Metabolic Syndrome and Cardiovascular Disease: Pathogenesis
    Metabolic Syndrome, Microalbuminuria and Chronic Kidney Disease
    Cardiometabolic Syndrome and Diabetes Mellitus
    Cardiometabolic Syndrome: Management
    Hypertension, Kidney Disease, Insulin Resistance
    Discussion

  2. Should Patients With Metabolic Syndrome Be Routinely Screened for GFR and Microalbuminuria? Implications of Observations for Treatment Plans
    by Robert D. Toto, MD
    Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
    Role of Obesity in Metabolic Syndrome and Chronic Kidney Disease
    Microalbuminuria and Diabetes
    Microalbuminuria: Relationship With Cardiovascular/Kidney Disease and Insulin Sensitivity
    Inflammation
    Dyslipidemia
    Treatment Implications

  3. The Metabolic Syndrome Patient With Hypertension: Reducing Risk for Cardiovascular Disease and Stroke
    by Kenneth A. Jamerson, MD
    Diabetes: The Problem
    Glucose Abnormalities: The Population
    The Tecumseh Study
    Clinical Trials: HOPE, LIFE, INVEST
    Clinical Trials: ALLHAT, VALUE, GEMINI
    Mechanisms
    Treatment Recommendations and Management
    Conclusions

  4. Go to Test Questions
Take this program with you!
Download this Web Conference as an MP3 and load it onto your iPod or other portable audio player for audio CME on-the-go.
audio MP3 Audio file James R. Sowers, MD
(Right-click and select "Save Target As…" to download)
audio MP3 Audio file Robert D. Toto, MD
(Right-click and select "Save Target As…" to download)
audio MP3 Audio file Kenneth A. Jamerson, MD
(Right-click and select "Save Target As…" to download)
Give us feedback on this new feature
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 
Copyright © 2005 National Kidney Foundation.
Merck
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME/CE Information
 
nkf
The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Kidney Foundation designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Contact This Provider

This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity has been approved for 2.4 contact hours.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.